J. Jaspan

发表

Familial hyperinsulinemia due to a structurally abnormal insulin. Definition of an emerging new clinical syndrome.

K. Polonsky, R. Bergenstal, S. Shoelson, 1984, The New England journal of medicine.

Effect of Diabetes Mellitus on the Permeability of the Blood–Brain Barrier to Insulin

W. Banks, A. Kastin, J. Jaspan, 1997, Peptides.

Transport of Insulin Across the Blood-Brain Barrier: Saturability at Euglycemic Doses of Insulin

W. Banks, A. Kastin, J. Jaspan, 1997, Peptides.

Hyperinsulinism Complicating Control of Diabetes Mellitus by an Artificial Beta-Cell

D L Horwitz, J. Jaspan, A. Zeidler, 1980, Diabetes Care.

Biphasic Patterns of Peripheral Insulin and Glucose Levels After Lunch in Normal Subjects

E. Cauter, D. Robbins, J. Jaspan, 1987, Diabetes Care.

Influence of Aging on Hepatic and Peripheral Glucose Metabolism in Humans

M. Hawa, J. Jaspan, L. Disilvio, 1988, Diabetes.

Insulin and Glucagon Breakthrough of Somatostatin Suppression: Importance of Portal Vein Hormone Measurements

K. Polonsky, J. Jaspan, W. Pugh, 1981, Diabetes.

Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations.

A. Golay, G. Reaven, J. Jaspan, 1986, The Journal of clinical endocrinology and metabolism.

Importance of basal glucagon in maintaining hepatic glucose production during a prolonged fast in conscious dogs.

D. Wasserman, A. Cherrington, G. Hendrick, 1992, The American journal of physiology.

Relationship Between Decrements in Glucose Level and Metabolic Response to Hypoglycemia in Absence of Counterregulatory Hormones in the Conscious Dog

A. Cherrington, D. Neal, J. Jaspan, 1992, Diabetes.

C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog.

K. Polonsky, D. Cohen, T. Karrison, 1984, The Journal of clinical investigation.

Defects in beta-cell function in functional ovarian hyperandrogenism.

K. Polonsky, N. O'Meara, D. Ehrmann, 1993, The Journal of clinical endocrinology and metabolism.

Basal glucose homeostasis with and without fixed concentrations of glucagon and insulin.

J. Jaspan, P. Blix, J. Nabarro, 1987, Metabolism: clinical and experimental.

The Effects of Biosynthetic Human Proinsulin on Carbohydrate Metabolism

K. Polonsky, R. Bergenstal, R. Henry, 1984, Diabetes.

Taking control of diabetes.

J. Jaspan, 1995, Hospital practice.

Hypercalcemia in a Patient With AIDS and Pneumocystis Carinii Pneumonia

J. Jaspan, B. Ahmed, 1993 .

Circulating forms of somatostatinlike immunoreactivity in human plasma.

K. Polonsky, S. Shoelson, J. Jaspan, 1986, The American journal of physiology.

Effect of difference in glucose infusion rate on quantification of hepatic glucose production.

W. Sheu, G. Reaven, M. Wu, 1990, The Journal of clinical endocrinology and metabolism.

Case report: clinical hypocalcemia: the endocrine conference of the Alton Ochsner Medical Institutions and Tulane University Medical Center.

J. Jaspan, A. Odugbesan, M. Wiegand, 1994, The American journal of the medical sciences.

Postprandial Oscillatory Patterns of Blood Glucose and Insulin in NIDDM: Abnormal Diurnal Insulin Secretion Patterns and Glucose Homeostasis Independent of Obesity

J. Callés-Escandon, D. Robbins, J. Jaspan, 1989, Diabetes Care.

Total pancreatectomy increases the metabolic response to glucagon in humans.

R. Sherwin, J. Fortner, J. Jaspan, 1986, The Journal of clinical endocrinology and metabolism.

Does glucagon increase plasma free fatty acid concentration in humans with normal glucose tolerance?

G. Reaven, M. Wu, J. Jaspan, 1990, The Journal of clinical endocrinology and metabolism.

Pathogenesis and characterization of hyperglucagonemia in the uremic rat.

A. Katz, J. Jaspan, A. Rubenstein, 1976, The Journal of clinical investigation.

Glucagon and Renal Insufficiency

K. Polonsky, J. Jaspan, A. Rubenstein, 1983 .

Abnormalities in circulating beta cell peptides in chronic renal failure: comparison of C-peptide, proinsulin and insulin.

H. Kuzuya, J. Jaspan, P. Blix, 1977, The Journal of clinical endocrinology and metabolism.

Lack of Glucagon Response to Hypoglycemia in Type I Diabetics After Long-Term Optimal Therapy with a Continuous Subcutaneous Insulin Infusion Pump

K. Polonsky, R. Bergenstal, J. Jaspan, 1983, Diabetes.

Glucose Counterregulation in Patients After Pancreatectomy: Comparison With Other Clinical Forms of Diabetes

K. Polonsky, R. Bergenstal, K. Herold, 1984, Diabetes.

Relation of counterregulatory responses to hypoglycemia in type I diabetics.

K. Polonsky, R. Bergenstal, J. Jaspan, 1982, The New England journal of medicine.

Glucagon metabolism in the rat.

A. Katz, J. Jaspan, A. Rubenstein, 1978, The Journal of clinical investigation.

Evidence for a retroviral trigger in Graves' disease.

D. M. Sander, S. Tenenbaum, R. Garry, 1995, Autoimmunity.

Glucose ingestion in dogs alters the hepatic extraction of insulin. In vivo evidence for a relationship between biologic action and extraction of insulin.

K. Polonsky, J. Jaspan, 1982, The Journal of clinical investigation.

Role of Protein in Diabetes Control

J. Jaspan, R. Malik, 1989, Diabetes Care.

A familial glucagonoma syndrome: genetic, clinical and biochemical features.

K. Polonsky, P. Stacpoole, J. Jaspan, 1981, The American journal of medicine.

Circulating Glucagon Components: Significance in Health and Disease

J. Jaspan, A. Rubenstein, B. Gonen, 1977 .

Circulating Glucagon Plasma Profiles and Metabolism in Health and Disease

J. Jaspan, A. Rubenstein, 1977, Diabetes.

Pancreatic hormone profiles and metabolism posthepatectomy in the dog. Evidence for a hepatotrophic role of insulin, glucagon, and pancreatic polypeptide.

K. Polonsky, D. Cohen, J. Jaspan, 1984, Gastroenterology.

The Metabolic Clearance Rate of Glucagon

K. Polonsky, J. Jaspan, A. Rubenstein, 1983 .

Hepatic metabolism of glucagon in the dog: contribution of the liver to overall metabolic disposal of glucagon.

K. Polonsky, J. Jaspan, W. Pugh, 1981, The American journal of physiology.

Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.

A. Katz, J. Jaspan, A. Zeidler, 1976, The Journal of clinical investigation.

In vivo pulsatility of pancreatic islet peptides.

K. Polonsky, E. van Cauter, E. Cauter, 1986, The American journal of physiology.

Transhepatic glucagon gradients in man: evidence for glucagon extraction by human liver.

E. Rayfield, J. Jaspan, J. Ruddick, 1984, The Journal of clinical endocrinology and metabolism.

Differential immunoreactivity of plasma glucagon components in man: studies with different glucagon antibodies.

K. Polonsky, D. Soybel, E. Rayfield, 1983, The Journal of clinical endocrinology and metabolism.

Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction.

K. Polonsky, T. Schwartz, D. Cohen, 1983, The Journal of clinical investigation.

Hepatic and renal metabolism of somatostatin-like immunoreactivity. Simultaneous assessment in the dog.

K. Polonsky, J. Jaspan, M. Berelowitz, 1981, The Journal of clinical investigation.

The metabolic effects of biosynthetic human proinsulin in individuals with type I diabetes.

K. Polonsky, R. Bergenstal, A. Cherrington, 1984, The Journal of clinical endocrinology and metabolism.

Differences in the hepatic and renal extraction of insulin and glucagon in the dog: evidence for saturability of insulin metabolism.

K. Polonsky, J. Jaspan, D. Emmanouel, 1983, Acta endocrinologica.

Hepatic Extraction of Plasma Immunoreactive Glucagon Components: Predilection for 3500-dalton Glucagon Metabolism by the Liver

K. Polonsky, J. Jaspan, A. Rubenstein, 1981, Diabetes.

The role of the liver in glucagon metabolism.

J. Jaspan, A. Rubenstein, A. Moossa, 1977, The Journal of clinical investigation.

Eating attitudes and glucose tolerance in anorexia nervosa patients at 8-year followup compared to control subjects

R. Casper, J. Jaspan, A. Rubenstein, 1988, Psychiatry Research.

Hormone and metabolite plasma levels after oral glucose in bulimia and healthy controls

R. Casper, J. Jaspan, A. Rubenstein, 1988, Biological Psychiatry.

Insulin Secretory Profiles and C-Peptide Clearance Kinetics at 6 Months and 2 Years After Kidney-Pancreas Transplantation

J. Sturis, K. Polonsky, E. Cauter, 1992, Diabetes.

Mechanism of Metformin Action in Non-Insulin-Dependent Diabetes

J. Jaspan, A. Kurtz, L. Disilvio, 1987, Diabetes.

Reduction in Portal Vein Blood Flow by Somatostatin

K. Polonsky, J. Jaspan, Michael Lewis, 1979, Diabetes.

The effect of somatostatin on postresectional ileal hyperplasia.

A. Moossa, J. Jaspan, S. Holmes, 1982, Endocrinology.

Genetic, Clinical and Biochemical Features

P. Stacpoole, J. Jaspan, D. Rabin, 1981 .

The in vivo metabolism of somatostatin 28: possible relationship between diminished metabolism and enhanced biological action.

N. Ling, K. Polonsky, J. Jaspan, 1982, Endocrinology.

Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies.

J. A. Scarlett, J. Olefsky, J. Jaspan, 1977, The New England journal of medicine.

Glucagon Immunoreactivity and Chromatographic Profiles in Pancreatectomized Humans: Paradoxical Response to Oral Glucose

J. Fortner, J. Jaspan, D. Bajorunas, 1986, Diabetes.

Evidence for the Presence of Somatostatin 28 in Plasma

K. Polonsky, S. Shoelson, J. Jaspan, 1982, Diabetes.

Heterogeneity of plasma glucagon in man.

A. Katz, J. Jaspan, A. Rubenstein, 1976, Metabolism: clinical and experimental.

Metabolic effects of theophylline in preterm infants.

T. Yeh, R. Pildes, J. Jaspan, 1981, The Journal of pediatrics.

The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease.

D. M. Sander, S. Tenenbaum, R. Garry, 1996, The Journal of clinical endocrinology and metabolism.

A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients.

J. Schneider, J. Jaspan, N. Haines, 1981, Gastroenterology.

Predominance of renal and absence of hepatic metabolism of pancreatic polypeptide in the dog.

W. Hagopian, K. Polonsky, D. Cohen, 1983, The American journal of physiology.

Clinical studies with an aldose reductase inhibitor in the autonomic and somatic neuropathies of diabetes.

V. Towle, K. Herold, R. Maselli, 1986, Metabolism: clinical and experimental.

TREATMENT OF SEVERELY PAINFUL DIABETIC NEUROPATHY WITH AN ALDOSE REDUCTASE INHIBITOR: RELIEF OF PAIN AND IMPROVED SOMATIC AND AUTONOMIC NERVE FUNCTION

K. Herold, R. Maselli, J. Jaspan, 1983, The Lancet.

Hirsutism: a brief review.

J. Jaspan, B. Ahmed, 1994, The American journal of the medical sciences.

Hepatic insulin and glucagon extraction after their augmented secretion in dogs.

J. Jaspan, S. Röjdmark, M. Chou, 1978, The American journal of physiology.

Permeability of the blood-brain barrier to amylin.

W. Banks, A. Kastin, L. Maness, 1995, Life sciences.

Plasma glucagon, insulin and glucose responses to intravenous arginine infusion in the rat.

A. Katz, J. Jaspan, A. Rubenstein, 1978, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Metabolic studies during normoglycaemic clamping of insulin-dependent diabetics using a glucose-controlled insulin infusion system.

K. Alberti, W. Stubbs, J. Jaspan, 1979, Hormone and metabolic research. Supplement series.

Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus.

A. Golay, G. Reaven, J. Jaspan, 1987, The Journal of clinical endocrinology and metabolism.

Regional variation in transport of pancreatic polypeptide across the blood-brain barrier of mice

W. Banks, A. Kastin, J. Jaspan, 1995, Pharmacology Biochemistry and Behavior.

First report of recombination between the HLA-DR and HLA-DQ loci within a family.

J. Jaspan, K. Sullivan, M. Bryer‐Ash, 1997, Human Immunology.

Counterregulation During Hypoglycemia Is Directed by Widespread Brain Regions

A. Cherrington, S. Davis, D. Neal, 1993, Diabetes.

Pharmacological Inhibition of Aldose Reductase in Human Diabetic Neuropathy

J. Jaspan, 2012, Drugs.

Treatment of diabetic neuropathy with inhibitors of the aldose reductase enzyme.

J. Jaspan, A. Green, 1990, The Journal of diabetic complications.

Influence of long-term aldose reductase inhibitor therapy on autonomic dysfunction of urinary bladder, stomach and cardiovascular systems in diabetic patients.

S. Chung, J. Jaspan, H. Schoenberg, 1987, Diabetes research and clinical practice.

Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders

D. M. Sander, Y. Shoenfeld, M. Gershwin, 1998, The Lancet.

Aldose reductase inhibition improves nerve conduction velocity in diabetic patients.

J. Halter, K. Polonsky, M. Pfeifer, 1983, The New England journal of medicine.

Role of Brain in Counterregulation of Insulin-Induced Hypoglycemia in Dogs

A. Cherrington, J. Jaspan, D. Neal, 1989, Diabetes.

Delirium and neuromuscular symptoms in an elderly man with isolated corticotroph-deficiency syndrome completely reversed with glucocorticoid replacement.

J. Jaspan, V. Fang, 1989, The Journal of clinical endocrinology and metabolism.

Leptin enters the brain by a saturable system independent of insulin

W. Banks, A. Kastin, L. Maness, 1996, Peptides.

Systematic Approach to Diagnosis and Management of Biphasic Insulin Allergy with Local Anti-Inflammatory Agents

J. Loeb, K. Herold, J. Jaspan, 1989, Diabetes Care.

Study of Passage of Peptides across the Blood–Brain Barrier: Biological Effects of cyclo(His‐Pro) after Intravenous and Oral Administration

A. Kastin, J. Jaspan, WILLIAM A. BANKS and, 1994, Annals of the New York Academy of Sciences.

Orally administered cyclo(His-Pro) reduces ethanol-induced narcosis in mice

W. Banks, A. Kastin, J. Jaspan, 1992, Pharmacology Biochemistry and Behavior.

Nerve conduction velocity in diabetes.

J. Halter, B. Shahani, R. Young, 1983, The New England journal of medicine.

Compartmental modeling of glucagon kinetics in the conscious dog.

C Cobelli, D W Neal, C. Cobelli, 1995, Metabolism: clinical and experimental.

Pharmacology Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function Lancet, ii (1983) 758–762

K. Herold, R. Maselli, J. Jaspan, 1984, Pain.

The influence of graded hyperglycemia with and without physiological hyperinsulinemia on forearm glucose uptake and other metabolic responses in man.

J. Jaspan, P. Blix, J. Nabarro, 1986, The Journal of clinical endocrinology and metabolism.

Selective, Physiological Transport of Insulin Across the Blood-Brain Barrier: Novel Demonstration by Species-Specific Radioimmunoassays

W. Banks, A. Kastin, J. Jaspan, 1997, Peptides.

Hypoglycemic Peripheral Neuropathy in Association with Insulinoma: Implication of Glucopenia Rather Than Hyperinsulinism Case Report and Literature Review

J. Jaspan, A. Rubenstein, R. Wollman, 1982, Medicine.

Myocardial mechanics in young adult patients with diabetes mellitus: effects of altered load, inotropic state and dynamic exercise.

R. Lang, K. Borow, A. Neumann, 1990, Journal of the American College of Cardiology.

Radioactively iodinated cyclo(His-Pro) crosses the blood-brain barrier and reverses ethanol-induced narcosis.

W. Banks, A. Kastin, J. Jaspan, 1993, The American journal of physiology.

Sodium bicarbonate therapy in severe diabetic ketoacidosis.

J. Jaspan, E. Lever, 1983, The American journal of medicine.

Hepatic glucagon clearance during insulin induced hypoglycemia.

K. Herold, J. Jaspan, J B Jaspan, 1986, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy.

K. Herold, J. Jaspan, C. Bartkus, 1985, The American journal of medicine.

Sympathetic skin response in diabetic neuropathy

J. Spire, R. Maselli, B. Soliven, 1987, Muscle & nerve.

Oscillatory Insulin Secretion After Pancreas Transplant

M. Byrne, J. Sturis, K. Polonsky, 1993, Diabetes.

Bacteriuria in Black diabetics.

J. Jaspan, L. Krut, C. Mangera, 1977, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Glucagon does not increase plasma free fatty acid and glycerol concentrations in patients with noninsulin-dependent diabetes mellitus.

W. Sheu, K. Polonsky, G. Reaven, 1993, The Journal of clinical endocrinology and metabolism.

Comparison of sympathetic skin response with quantitative sudomotor axon reflex test in diabetic neuropathy

J. Spire, R. Maselli, B. Soliven, 1989, Muscle & nerve.

AN‘ARTIFICIAL BETA CELL’FOR CONTROL OF DIABETES MELLITUS: EFFECT ON PLASMA GLUCAGON LEVELS

J. Jaspan, A. Zeidler, B. Langer, 1979, Clinical endocrinology.